Skip to main content

LT (Letrozole 2.5 mg)

Pill with imprint LT is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Accord Healthcare Inc.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LT

Letrozole 2.5 mg LT
Letrozole 2.5 mg LT
Letrozole 2.5 mg LT

Letrozole

Imprint
LT
Strength
2.5 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Accord Healthcare Inc
National Drug Code (NDC)
16729-0034
Inactive Ingredients
silicon dioxide, hypromellose 2910 (6 mPa.s), ferric oxide yellow, lactose monohydrate, magnesium stearate, corn starch, microcrystalline cellulose, polyethylene glycol 400, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "LT"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.